“We have tested the BioPen® in different applications here at Karolinska Institutet and in collaboration with a research group at Göteborg University. I consider the BioPen® very valuable for applying compounds or drugs to single cells in culture as well as to specific cell layers in brain slices”.
Associate Prof. Kent Jadermark at Karolinska Institutet
“The major advantages of the BioPen® system for us is that it is rather smooth to set up an experiment, both hardware and software are easy to handle and it allowed us to rapidly switch between flows. Aside from this, we highly appreciated the support received from the people from Fluicell before and after we bought the BioPen® system.”
Dr. Niek Welkenhuysen at Chalmers University
LOCALIZED SUPERFUSION DEVICE FOR SINGLE-CELL EXPERIMENTS
Exploring the ability to interrogate one or a small numbers of cells in complex environments.See more
AUTOMATED PERFUSION SYSTEM FOR PATCH-CLAMP
Taking your patch-clamp experiments to new horizons.See more
Subscribe here to press releases.
|03 November 2017||Fluicell AB has in-licensed the Dynaflow Resolve|
|24 July 2017||Another New Patent in the USA for the BioPen System|
|05 July 2017||Private Placement|
|14 June 2017||New BioPen Patent in the USA|